Microfluidic Organ-on-a-Chip Technology for Advancement of Drug Development and Toxicology.
about
Microfluidic Organ/Body-on-a-Chip Devices at the Convergence of Biology and Microengineering.Droplet control technologies for microfluidic high throughput screening (μHTS).Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.Transient Biocompatible Polymeric Platforms for Long-Term Controlled Release of Therapeutic Proteins and Vaccines.Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment.Cell stretching devices as research tools: engineering and biological considerations.Microdevice Platform for In Vitro Nervous System and Its Disease Model.A Role for 3D Printing in Kidney-on-a-Chip Platforms.Models for the study of nasal and sinus physiology in health and disease: A review of the literature.Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.Multilineage Constructs for Scaffold-Based Tissue Engineering: A Review of Tissue-Specific Challenges.Microfibers as Physiologically Relevant Platforms for Creation of 3D Cell Cultures.Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.A model of dormant-emergent metastatic breast cancer progression enabling exploration of biomarker signatures.Organ-on-a-Chip Technology for Reproducing Multiorgan Physiology.Controlling Differentiation of Stem Cells for Developing Personalized Organ-on-Chip Platforms.3D Miniaturization of Human Organs for Drug Discovery.A disease model of diabetic nephropathy in a glomerulus-on-a-chip microdevice.Recent advances in microfluidic technologies for cell-to-cell interaction studies.Modeling convection-diffusion-reaction systems for microfluidic molecular communications with surface-based receivers in Internet of Bio-Nano Things.Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.Human tissue-engineered skeletal muscle: a novel 3D in vitro model for drug disposition and toxicity after intramuscular injection
P2860
Q26774240-165C2FBD-DBDB-4AEF-98B5-BFB0762CA497Q38669110-121E5889-1CBF-4615-9B1E-2ABB87408226Q38675826-4B431932-7A95-4D7A-A406-40ADBDB1BA7BQ38762655-68410BAE-E5DE-41BF-AE96-59D2C33648B1Q38810462-D36535DF-8960-4410-ACC6-B62785A875F2Q38839495-62A68334-2A43-4D79-8473-DAD4647C59ECQ41670106-110AF8F9-A98F-405A-AD1A-B05A62B40FC1Q42330872-376C449B-6FCF-4AC4-9C01-3C0502761127Q47138279-D89A7BF1-10BD-4EB1-8B56-3BD8BE1846F0Q47283219-DE349906-C414-40F9-815B-83033C332F3CQ47295300-EEA2254C-1092-4D05-BAD7-444F73300162Q47338418-FDB82682-A260-4297-85E3-B0DF534D5473Q47442360-DED3A15C-A509-477A-9287-535400134638Q47558500-8E5E8B72-DAE3-4B2E-9668-E9D369242213Q47637355-29CA9BAF-9474-4F25-BAF7-5873CCAFDE14Q47675953-693B8143-1E40-43D8-B000-EB8E37B135A1Q47698887-38F284C0-D699-4E12-9D6F-BADB93F0CF9DQ48265700-3C6CAAC8-1D89-4428-9181-691EA666D0CEQ49978957-2F11E06C-FD3D-40FF-A1CF-58B68E8DBD5DQ50055404-AAD222BD-DB66-449F-A42F-2E898D8FD1AFQ50868047-5C1297C7-201A-49A5-B029-46566398DB2EQ58778324-20188949-0BE4-4B05-8AAD-3D9F6D507288
P2860
Microfluidic Organ-on-a-Chip Technology for Advancement of Drug Development and Toxicology.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Microfluidic Organ-on-a-Chip T ...... ug Development and Toxicology.
@en
type
label
Microfluidic Organ-on-a-Chip T ...... ug Development and Toxicology.
@en
prefLabel
Microfluidic Organ-on-a-Chip T ...... ug Development and Toxicology.
@en
P2093
P356
P1476
Microfluidic Organ-on-a-Chip T ...... ug Development and Toxicology.
@en
P2093
Jeremy D Caplin
Myra R James
Norma G Granados
P304
P356
10.1002/ADHM.201500040
P577
2015-03-26T00:00:00Z